Familial Hypercholesterolemia

Best of Preventive Cardiology Summit: Applying New Options for Optimal CV Risk Management

Best of Preventive Cardiology Summit: Applying New Options for Optimal CV Risk Management

In the United States, cardiovascular disease (CVD) is the leading cause of…

Expiration Date: 1/20/2021

Max Credits: 0

View Activity

Cardiovascular Risk Reduction With PCSK9 Inhibitors: Evolving Evidence, Recommendations, and Controversies

Cardiovascular Risk Reduction With PCSK9 Inhibitors: Evolving Evidence, Recommendations, and Controversies

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have prov…

Expiration Date: 7/15/2020

Max Credits: 0

View Activity

Back to the Future: Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future

Back to the Future: Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future

With each passing year we gain new insight and understanding around the cl…

Expiration Date: 8/11/2018

Max Credits: 0

View Activity

Treating Familial Hypercholesterolemia

Treating Familial Hypercholesterolemia

Patients at high risk for cardiovascular disease, such as those with famil…

Expiration Date: 11/17/2017

Max Credits: 0

View Activity

Identifying Familial Hypercholesterolemia – It’s Not as Rare as You Think

Identifying Familial Hypercholesterolemia – It’s Not as Rare as You Think

Patients at high risk for cardiovascular disease, such as those with famil…

Expiration Date: 12/8/2019

Max Credits: 0

View Activity

Progress Toward a Consensus on Cardiovascular Risk Reduction

Progress Toward a Consensus on Cardiovascular Risk Reduction

Dr. Wright assesses the impact of LDL-C reduction in patients with complex…

Expiration Date: 2/23/2017

Max Credits: 0

View Activity